ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

AACR Using Its Clout To Urge Higher NCI Budget

May 24, 1991

Mass. Public Health Commissioner Koh Named To NCAB; Kovach To Direct Long Island Center.

October 27, 2000

Simmons Cancer Center at UT Southwestern Wins NCI Comprehensive Designation and $7.5 Million.

September 10, 2010

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Funding Opportunities: Aging Institute Offers Program Announcement

February 6, 1998

Preventive Ovarian Surgery Recommended For Women with BRCA1 Mutations by Age 35

February 28, 2014